HeXun Biosciences Co., Ltd.
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.
Market Cap & Net Worth: HeXun Biosciences Co., Ltd. (6986)
HeXun Biosciences Co., Ltd. (TWO:6986) has a market capitalization of $76.33 Million (NT$2.53 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #23052 globally and #1351 in its home market, demonstrating a 5.17% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HeXun Biosciences Co., Ltd.'s stock price NT$54.90 by its total outstanding shares 46000000 (46.00 Million).
HeXun Biosciences Co., Ltd. Market Cap History: 2026 to 2026
HeXun Biosciences Co., Ltd.'s market capitalization history from 2026 to 2026. Data shows growth from $76.33 Million to $76.33 Million (0.00% CAGR).
HeXun Biosciences Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HeXun Biosciences Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6986 by Market Capitalization
Companies near HeXun Biosciences Co., Ltd. in the global market cap rankings as of March 19, 2026.
Key companies related to HeXun Biosciences Co., Ltd. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
HeXun Biosciences Co., Ltd. Historical Marketcap From 2026 to 2026
Between 2026 and today, HeXun Biosciences Co., Ltd.'s market cap moved from $76.33 Million to $ 76.33 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$76.33 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of HeXun Biosciences Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $76.33 Million USD |
| MoneyControl | $76.33 Million USD |
| MarketWatch | $76.33 Million USD |
| marketcap.company | $76.33 Million USD |
| Reuters | $76.33 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.